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Abstract: Investigations regarding renal clearance and urinary excretion of ciprofloxacin were carried out in buffaloes,
cows, sheep, and goats. The drug was administered intramuscularly at a dose of 5 mg/kg body weight. The plasma and
urine concentrations of the drug were determined with HPLC. Renal clearance of endogenous creatinine was used as an
index of glomerular filtration rate (GFR). In buffaloes, it was 0.72 ± 0.15 (mean ± SE), in cows 0.36 ± 0.09, in sheep 1.33
± 0.35, and in goats 1.87 ± 0.38 mL/min/kg. The renal clearance of ciprofloxacin in buffaloes was 0.47 ± 0.08, in cows 0.29
± 0.08, in sheep 0.39 ± 0.06, and in goats 0.98 ± 0.17 mL/min/kg. Besides glomerular filtration, ciprofloxacin was
reabsorbed from the renal tubules of all ruminants and actively secreted in buffaloes. The cumulative percentage of
intramuscular dose of ciprofloxacin excreted into the urine over 10 h in buffaloes was 10.04 ± 1.17, in cows 7.22 ± 1.12,
in sheep 11.26 ± 1.74, and in goats 13.03 ± 2.07. Species difference in the urinary excretion of ciprofloxacin revealed that
the excretion of the drug was highest in goats, followed by sheep, buffaloes, and cows. This species variation in the
percentage of urinary excretion in these ruminants coincides with their respective GFR being the highest in goats and
lowest in cows.
Key words: Ciprofloxacin, domestic ruminants, renal clearance, urinary excretion

Introduction
It has been observed that the pharmacokinetic
behaviour, optimal dosage, renal clearance, and urinary
excretion of many investigated drugs were different
under local conditions when compared with the values
given in the literature by Nawaz et al. (1) and Javed et al.
(2,3). The fluoroquinolones are synthetic antibacterial
agents, used for the treatment of a variety of bacterial
infections. All fluoroquinolones exhibit such
distributional and antimicrobial properties that make
them potentially useful in veterinary medicine.
Vancutsem et al. (4) reported that these have extensive

application in clinical practice because of their good
bioavailability and pharmacokinetic profile, arousing
great interest in the field of chemotherapy.
Ciprofloxacin is an important member of the
fluoroquinolone group of antibiotics. It is a broad
spectrum antibiotic used to combat various infectious
diseases in humans and animals (5). However, the
biodisposition of ciprofloxacin has not been studied in
local ruminant species. Keeping in view the vast clinical
use of ciprofloxacin in local animals, the present study
was designed to determine the renal handling of this
drug in domestic ruminant species.

* E-mail: sandhu_drijaz@yahoo.com
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Materials and methods
Experimental animals
Renal clearance and urinary excretion of
ciprofloxacin were investigated in domestic
ruminants, 8 each in Nili Ravi buffaloes (368 ± 44 kg),
Sahiwal cows (280 ± 13 kg), Lohi sheep (40 ± 2 kg),
and Teddy goats (35 ± 2 kg). In this way a total of 32
experiments were conducted. All the ruminant
animals were clinically healthy adult females
maintained under similar environmental and
management conditions at the Livestock
Experimental Farm, Institute of Nutrition and Feed
Technology, University of Agriculture, Faisalabad,
Pakistan. All the animals were stall fed with dry wheat
straw and green fodder of the season. The animals had
free access to drinking water. The experiments were
performed during November and December 2006.
Methodology
In each animal, one of the jugular veins was
cannulated in the standing position under strict
aseptic conditions with plastic cannula No. 90 (Protex
Ltd., England) for the collection of blood samples. A
sterilised disposable balloon catheter (Rush No. 14, 30
mL) was inserted into the urinary bladder through the
urethra of each animal. The external opening of the
catheter was connected through rubber tubing to a
urine collecting reservoir in which all the voided
urine was quantitatively collected. A commercial
injectable preparation of ciprofloxacin, CIPROCIN100®, batch No. 539009 (Han Dong Corporation Ltd.,
Korea) was used in these studies. Each millilitre of the
injection contained 100 mg of ciprofloxacin. A single
dose of the above-mentioned preparation of
ciprofloxacin was injected intramuscularly into the
neck region at a dose rate of 5 mg/kg body weight. In
all experiments, prior to drug administration, a blank
blood sample and blank urine sample were collected.
For renal clearance studies, the urinary bladder was
emptied completely and washed with distilled water
through the catheter 45 min after the drug
administration. After washing, the first urine sample
was collected at 75 min and then more samples were
collected at 105, 135, and 165 min, post-drug
administration. The volume of each urine sample was
measured. Following drug administration, blood
samples were drawn at 30, 60, 90, and 120 min. Blood
samples were collected in heparinized plastic
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centrifuge tubes. The pH of blood and urine samples
was recorded by a pH meter (Beckman HS, Germany)
with a glass electrode at 37 °C. Blood samples were
centrifuged and plasma was separated and stored at
-20 °C until analysis. For the study of urinary
excretion, the urine voided until 4, 6, 8, and 10 h after
drug administration was collected quantitatively. The
pH of all urine samples was recorded as mentioned
earlier.
Analytical procedures
Ciprofloxacin
Ciprofloxacin concentration in plasma and urine
was determined using HPLC according to the method
described by Soback et al. (6). Chromatography was
performed with a high performance liquid
chromatograph (Sykam, S-1122) and analytes were
determined using UV/Vis detector (Sykam, S-3210).
The output of the detector was monitored with
computer software (Peak Simple Chromatography
Data System, Buck Scientific Inc., East Norwalk, CT,
USA). A stainless steel column packed with YMC
pack A-312 (Thermo Hypersil-Keystone, BDS-C18
with 250 × 4.6 mm dimensions and 5 μm particle size)
was used. The column was protected with a precolumn (Guard-Pak™) filled with a μBondapak™ C18
cartridge (Thermo Hypersil, England). Separation of
ciprofloxacin was achieved at 37 °C, using an isocratic
mode. The mobile phase consisted of a mixture of 800
mL of 14 mL/L phosphoric acid and 200 mL of
acetonitrile per litre. The UV detector was set at 275
nm and the flow rate was 1 mL/min. The lower limit
of detection was 0.075 μg/mL while the limit of
quantitation was 0.25 μg/mL.
For the determination of the ciprofloxacin
concentration in the plasma samples, in a centrifuge
tube 2 mL of acetonitrile was added to 1 mL of plasma
or plasma calibrator. The mixture was vortexed for 1
min and centrifuged for 30 min at 4000 rpm. The
supernatant was transferred into a glass tube and
evaporated to dryness in a water bath. The residue was
then reconstituted in 10 μL of IS and 1 mL of 14 mL/L
phosphoric acid. The final solution was again
vortexed for 30 s and filtered through cellulose acetate
membrane filter (Sartorius AG, Germany, 13 mm
diameter and 0.2 μm pore size), and 20 μL was
injected into the HPLC system.
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For determination of ciprofloxacin concentration
the urine samples were diluted 1:20 (by volume) with
the mobile phase. In a centrifuge tube 10 μL of the
working solution of paracetamol was added to 1 mL of
the diluted urine. The mixture was vortexed and
filtered, and 20 μL was injected directly into the HPLC
system.
Creatinine
The concentration of creatinine in plasma and
urine samples was determined as described by
Thomas (7) with the help of BTS-330 (Bio-Systems
S.A., Spain) according to the Jaffe reaction. Creatinine
forms an orange-red complex in alkaline picrate
solution. The difference in absorbance at fixed times
during the conversion is proportional to the
concentration of creatinine in the sample. For this
purpose 50 μL plasma sample was mixed with 1000
μL a mono reagent having 4 parts of 0.16 mol/L
sodium hydroxide and 1 part of 4.0 mmol/L picric
acid and the first absorbance was read after 60 s and
the second absorbance after a further 120 s.
Concentration of creatinine was determined from the
difference between these 2 absorbance values. The
creatinine concentration in urine samples was
determined by the same method but samples were
diluted 50 times with the distilled water before mixing
them with mono reagent as the creatinine
concentration is several-fold higher in urine as
compared to plasma.
Calculations
Ciprofloxacin
The concentration of ciprofloxacin in plasma and
urine samples was determined by the following
regression equation: y = bx + a, where y = peak area
for unknown concentration of ciprofloxacin
determined through HPLC, a = intercept, b = slope of
the regression line, and x = concentration of
ciprofloxacin.
Renal clearance
The renal clearance of endogenous creatinine was
used for the estimation of glomerular filtration rate
(GFR). Renal clearance of ciprofloxacin and
endogenous creatinine was calculated by the formula
Clren = Uc × Uv/Pc, where Clren is renal clearance, and
Uc and Pc are concentrations of a substance in urine

and plasma, respectively. Uv is urine rate flow
(diuresis, mL/min/kg). Influence of urine pH, rate of
urine flow, and plasma drug concentration on the
renal clearance of drug was examined by
regression/correlation analysis.
Urinary excretion
The mean ± SE (standard error of mean) values for
the ciprofloxacin in the urine samples of buffaloes,
cows, sheep, and goats at different time intervals after
the intramuscular injection were calculated. The urine
concentrations versus time data were used to
determine the cumulative percentage of the dose
excreted until 10 h after the intramuscular drug
administration.
Statistical analysis
The mean values and standard error of mean
(±SE) for each concentration and parameter were
calculated. The relationship between the urine flow,
blood pH, and plasma concentration of the drug was
calculated with regression correlation analysis.
Statistical analysis was carried out with PC-program
MStat-C by Freed, R.D. and Eisensmith. S.P.,
Michigan State University, USA, and the figures were
prepared using Microsoft Excel version 2003.
Results
Renal clearance
Mean ± SE values of diuresis, plasma, and urine
concentration and renal clearance of endogenous
creatinine and ciprofloxacin for 32 sampling periods,
4 each in 8 buffaloes, cows, sheep, and goats are
presented in the Table.
The values of rate of urine flow were 0.012 ± 0.003
mL/min/kg in buffaloes, 0.01 ± 0.003 mL/min/kg in
cows, 0.032 ± 0.007 mL/min/kg in sheep, and 0.073 ±
0.014 mL/min/kg in goats. The pH in blood and urine
was 8.41 ± 0.03 and 9.08 ± 0.05, 8.41 ± 0.03 and 9.08
± 0.05, 7.29 ± 0.02 and 8.18 ± 0.01, and 7.29 ± 0.02
and 8.18 ± 0.01, respectively, in buffaloes, cows, sheep,
and goats. The mean ± SE values for the concentration
of endogenous creatinine in plasma and urine were
18.94 ± 0.60 and 1132.7 ± 44.85 μg/mL, 20.37 ± 0.36
and 778.12 ± 51.86 μg/mL, 15.69 ± 0.59 and 615.6 ±
37.6 μg/mL, and 14.47 ± 0.50 and 364.1 ± 13.2 μg/ml
in buffaloes, cows, sheep, and goats, respectively,
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Table. Mean ± SE values for body weight, diuresis, plasma and urine concentrations and renal clearance of endogenous creatinine and
ciprofloxacin in 8 female buffaloes, cows, sheep and goats following a single intramuscular administration of ciprofloxacin at dose
rate of 5 mg/kg body weight.

Body
Ruminant

Creatinine conc.

Ciprofloxacin conc.

Renal clearance

μg/mL

μg/mL

mL/min/kg

pH

weight

Diuresis

(kg)

mL/min/kg

Blood

Urine

Plasma

Urine

Plasma

Urine

Creat.

Cipro.

Buffaloes

367.6 ± 47.39

0.012 ± 0.003

8.41 ± 0.03

9.08 ± 0.05

18.94 ± 0.60

1132.7 ± 44.85

3.84 ± 0.19

156.80 ± 9.25

0.72 ± 0.15

0.47 ± 0.08

0.69 ± 0.06

Cows

279.5 ± 13.55

0.010 ± 0.003

8.41 ± 0.03

9.08 ± 0.05

20.37 ± 0.36

778.12 ± 51.86

3.42 ± 0.21

97.75 ± 5.31

0.36 ± 0.09

0.29 ± 0.08

0.78 ± 0.05

Sheep

39.87 ± 2.30

0.032 ± 0.007

7.29 ± 0.02

8.18 ± 0.01

15.69 ± 0.59

615.6 ± 37.6

1.48 ± 0.09

18.60 ± 2.90

1.33 ± 0.35

0.39 ± 0.06

0.37 ± 0.07

Goats

35.38 ± 1.97

0.073 ± 0.014

7.29 ± 0.02

8.18 ± 0.01

14.47 ± 0.50

364.1 ± 13.2

1.38 ± 0.15

18.60 ± 2.90

1.87 ± 0.38

0.98 ± 0.17

0.57 ± 0.08

species

Ratio
Cip/Creat.

Each data point shows mean of 32 observations in 8 experiments, each consisting of 4 experimental periods.

while the respective values of ciprofloxacin
concentration in buffaloes, cows, sheep, and goats
were 3.84 ± 0.19 and 156.80 ± 9.25 μg/mL, 3.42 ±
0.21 and 97.75 ± 5.31 μg/mL, 1.48 ± 0.09 and 18.60
± 2.90 μg/mL, and 1.38 ± 0.15 and 18.6 ± 2.90
μg/mL. The renal clearance of endogenous creatinine
and ciprofloxacin was in buffaloes 0.72 ± 0.15 and
0.47 ± 0.08 mL/min/kg, in cows 0.36 ± 0.09 and 0.29
± 0.08 mL/min/kg, in sheep 1.33 ± 0.35 and 0.39 ±
0.06 mL/min/kg, and in goats 1.87 ± 0.39 and 0.98 ±
0.17 mL/min/kg. The ratio between the clearance of
ciprofloxacin and the clearance of endogenous
creatinine was 0.69 ± 0.06, 0.78 ± 0.05, 0.37 ± 0.07,
and 0.57 ± 0.08 in buffaloes, cows, sheep, and goats,
respectively. In buffaloes the regression correlation
analysis revealed a significant (P < 0.05) negative
correlation (r = -0.436) between plasma
concentration of ciprofloxacin and its renal clearance
(Figure 1) while diuresis also revealed a significant
(P < 0.05) positive correlation (r = 0.369) with renal
clearance (Figure 2). However, urine pH (r = 0.141)
did not show any significant correlation with the
renal clearance of the drug. Both in cows and sheep
the regression/correlation analysis did not show any
influence of diuresis (r = 0.143, 0.132), pH of urine (r
= 0.050, 0.065), or plasma concentration of
ciprofloxacin (r = -0.247, -0.213) on the renal
clearance of the drug. In goats a significant (P < 0.05)
positive correlation (r = 0.420) between diuresis and
the renal clearance of ciprofloxacin was observed
(Figure 3). However, plasma concentration (r = 0.087) and urine pH (r = 0.131) did not show any
influence on the renal clearance of the drug.
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Urinary excretion
The mean ± SE values of the cumulative
percentage of dose excreted for each species are
presented in Figure 4. This figure shows that the
cumulative percentage of dose of ciprofloxacin
excreted at 10 h in the urine of goats was 13.03 ± 2.07,
followed by 11.26 ± 1.74 in sheep, 10.04 ± 1.17 in
buffaloes, and 7.22 ± 1.12 in cows.
Discussion
The primary mechanism of renal excretion for
ciprofloxacin and all other fluoroquinolones is by
glomerular filtration (8). However, Blum (9) reported
that ciprofloxacin was eliminated by both the renal
(glomerular filtration and tubular secretion) and nonrenal (hepatic and trans-intestinal) routes.
In the present study the renal clearance of
endogenous creatinine was 0.723 ± 0.148 mL/min/kg.
The clearance value was lower than 1.74 mL/min/kg
(10) but higher than 0.44 and 0.34 mL/min/kg in
summer and winter, respectively (1), which appears
to be attributed to the normal biological variations.
The mean value for renal clearance of
ciprofloxacin in buffaloes was 0.469 ± 0.082
mL/min/kg. A significant (P < 0.05, Figure 1) negative
correlation between plasma concentration of
ciprofloxacin and ratio of renal clearance of
ciprofloxacin and renal clearance of endogenous
creatinine was attributed to the saturation of excretory
mechanism at higher drug plasma levels, which is
indicative of the involvement of active tubular
secretion. Diuresis revealed a significant (P < 0.05,
Figure 2) positive correlation with the renal clearance
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Figure 2. Effect of diuresis of ciprofloxacin on its renal clearance
in buffaloes. Each data point shows 1 of the 32
observations in 8 experiments, each consisting of 4
experimental periods.
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Figure 1. Effect of plasma concentration of ciprofloxacin on its
renal clearance in buffaloes. Each data point shows 1 of
the 32 observations in 8 experiments, each consisting of
4 experimental periods.
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Figure 3. Effect of diuresis of ciprofloxacin on its renal clearance
in goats. Each data point shows 1 of the 32 observations
in 8 experiments, each consisting of 4 experimental
periods.

Figure 4. Mean cumulative percent of ciprofloxacin
intramuscular dose (5 mg/kg) excreted in urine of
ruminant species.

ratio. This indicates that with increasing diuresis renal
clearance of ciprofloxacin also increased. This
observation also indicates that at lower diuresis the
drug had more time to stay in the tubules from where
it would be reabsorbed. Thus the renal handling of
ciprofloxacin in buffaloes besides glomerular
filtration involved active tubular secretion and back
diffusion also.

The renal clearance of endogenous creatinine was
0.362 ± 0.09 mL/min/kg, which was comparable to
0.49 mL/min/kg (3). However, this value was lower
than 0.60 ± 0.08 mL/min/kg (11).
Analysis of the data revealed that the rate of urine
flow, urine pH, and the plasma concentration of
ciprofloxacin did not influence the renal clearance of
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drug in cows. This indicates that the renal handling
of ciprofloxacin in cows mainly involves the
glomerular filtration.
The renal clearance of endogenous creatinine
showed a mean value of 1.325 ± 0.35 mL/min/kg,
which is comparable to previously reported values,
e.g. 1.0 mL/min/kg (12), and also with those in ewes,
1.05 ± 0.06 mL/min/kg, and sheep, 1.13 ± 0.24
mL/min/kg (13). However, the clearance value in the
present study is much higher than 0.042 ± 0.005
mL/min/kg (2) and lower than 17 mL/min/10 kg in
sheep (14).
In sheep regression/correlation analysis revealed
that there was no significant correlation between
diuresis, plasma concentration of ciprofloxacin, and
urine pH with the renal clearance of drug. Thus in
sheep the renal excretion of ciprofloxacin mainly
involved glomerular filtration.
The goats used in the present study showed a
mean value for the renal clearance of endogenous
creatinine of 1.87 ± 0.385 mL/min/kg. However, the
value was lower than the clearance in Danish goats of
26.2 mL/min/10 kg (15) but comparable with the local
goats, 1.43 and 1.86 mL/min/kg, during summer and
winter, respectively (1).
The analysis of data on diuresis, urine pH, plasma
concentration of ciprofloxacin, and renal clearance of
endogenous creatinine and ciprofloxacin showed a
significant (P < 0.05, Figure 3) positive correlation
between diuresis and renal clearance of the drug,
which is indicative of back diffusion. However, plasma
concentration of ciprofloxacin and urine pH did not
influence the renal excretion of the drug. Hence, renal
handling of ciprofloxacin in goats involves glomerular
filtration and back diffusion.
In indigenous buffaloes, cows, sheep, and goats
GFR is lower in the subtropical environment when
compared with the dwellers of temperate
environments as has been explained by an original
term “geonetics” reported by Nawaz et al. (1).
In all ruminant species the mean ± SE ratio of
renal clearance of ciprofloxacin and renal clearance of
endogenous creatinine was less than unity. This
reflects the lower renal clearance of drug than the
respective GFR in individual species (almost 2 times
in buffaloes, 1 time in cows, 3 times in sheep, and 2
308

times in goats), which is indicative of back diffusion of
the drug during its renal handling. It shows that
during renal clearance of ciprofloxacin almost 31%,
22%, 63%, and 43% of the drug is reabsorbed at the
kidney tubular level in buffaloes, cows, sheep, and
goats, respectively. Hence, on the basis of these
observations it is evident that besides glomerular
filtration back diffusion is involved in all ruminant
species during their renal excretion of the drug.
However, regression/correlation analysis also
evidenced the involvement of active tubular secretion
and back diffusion in buffaloes while only back
diffusion was manifested in goats.
Urinary excretion of endogenous and exogenous
substances is manipulated by multiple mechanisms of
glomerular filtration, tubular secretion, and
resorption in a passive or active way. Drugs are
regarded as interfering with homeostasis and thus
must be excreted by means of existing mechanisms.
Cumulative percentage of dose of ciprofloxacin
excreted at 10 h in the urine is maximum in goats
(13.03%) and minimum in cows (7.22%), followed by
intermediate values: 11.26% in sheep and 10.04% in
buffaloes (Figure 4). The species variation in the
percentage of urinary excretion in these domestic
ruminants coincides with their respective GFR values
being highest in goats, lowest in cows, and
intermediate in sheep and buffaloes.
Higher urinary excretion, 28.3% of intravenous
dose of ciprofloxacin after 24 hours, in buffalo calves
has been reported by Saini and Srivastava (16).
Besides ciprofloxacin, higher urinary excretion has
also been reported for other fluoroquinolones.
Urinary excretion of danofloxacin of 22.9% was
observed after 48 h of the drug administration in
buffalo calves reported by Sappal et al. (17). Montay et
al. (18) documented 29% urinary recovery of the
pefloxacin dose in mice, 37.8% in rats, 36.3% in dogs,
26.5% in monkeys, and 58.9% in humans. However,
contrary to the above findings, Singh and Srivastava
(19) reported a lower urinary excretion of
ciprofloxacin of 10% of intramuscular dose in crossbred cow calves.
Lower urinary excretion of ciprofloxacin in
domestic ruminants in the current investigation may
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be evidenced by the results regarding its renal
handling. These results show that regardless the
involvement of active tubular secretion in buffaloes
22%-63% of the administered dose of the drug has
been absorbed at kidney tubular level. For
ciprofloxacin being the zwitterions at physiological
pH, the pKa values have been reported as 6.1 and 7.8
at its carboxylic and amino groups, respectively.
Takács-Novák et al. (20) reported that ciprofloxacin
is most lipophilic drug. Moreover, if we consider
ciprofloxacin as a weakly basic drug with a pKa value
of 7.8, it means that 50% of the drug will be unionized at pH 7.8. When the pH of urine in domestic
ruminants increases, the drug will be more unionized. A high degree of un-ionization provides
more of the drug for reabsorption and therefore high
clearance values may not be observed when the pH of
urine is high.

Renal clearance of endogenous creatinine in
indigenous domestic ruminant species has been
found lower than that of their foreign counterparts.
Renal handling of ciprofloxacin besides glomerular
filtration involved back diffusion. Active tubular
secretion has been observed in buffaloes only. Urinary
excretion of ciprofloxacin in domestic ruminant
species was found to be lower than most literature
values and coincides with their respective GFR values
being the highest in goats, lowest in cows, and
intermediate in sheep and buffaloes.
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